← Open Payments lookup

SCOT YARNELL: Open Payments

NPI 1457914228 · BUFFALO, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$375 in 19 payments from 10 companies in 2025. Trend: 2023 $1,052 · 2024 $584 · 2025 $375

Food & beverage: $375
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.5$95
Teva Pharmaceuticals USA, Inc.3$62
ABBVIE INC.2$44
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$42
Janssen Pharmaceuticals, Inc2$41
Vanda Pharmaceuticals Inc.1$22
Janssen Scientific Affairs, LLC1$21
E.R. Squibb & Sons, L.L.C.1$18
Neurocrine BioSciences, Inc.1$17
Takeda Pharmaceuticals U.S.A., Inc.1$14

Products named: ABILIFY MAINTENA, VRAYLAR, REXULTI, CAPLYTA, INVEGA SUSTENNA, UZEDY, FANAPT, AUSTEDO XR.

Industry payments across KS — which companies pay providers there.